Clinical Trial Update: Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating trastuzumab with paclitaxel, carboplatin, and gemcitabine for advanced urothelial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• HERCEPTIN (trastuzumab)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Urologic Neoplasms | Phase 2 | Status: COMPLETED